References
- Kumar V, Abbas AK, Aster JC, Deyrup AT, Das A. Robbins and Kumar basic pathology. 11th ed. Philadelphia: Elsevier 2023:602-635
- Agarwal I, Blanco L. WHO classification. Available at. https://www.pathologyoutlines.com/topic/breast-malignantwhoclassification.html. Accessed September 18, 2023
- Ajkunic A, Skenderi F, Shaker N, Akhtar S, Lamovec J, Gatalica Z, et al. Acinic cell carcinoma of the breast: a comprehensive review. Breast 2022;66:208-216
- Conlon N, Sadri N, Corben AD, Tan LK. Acinic cell carcinoma of breast: morphologic and immunohistochemical review of a rare breast cancer subtype. Hum Pathol 2016;51:16-24
- Krizmanich-Conniff KM, Paramagul C, Patterson SK, Helvie MA, Roubidoux MA, Myles JD, et al. Triple receptor-negative breast cancer: imaging and clinical characteristics. AJR Am J Roentgenol 2012;199:458-464
- Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, et al. MR imaging features of triple-negative breast cancers. Breast J 2013;19:643-649
- Angelini G, Marini C, Iacconi C, Mazzotta D, Moretti M, Picano E, et al. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC). Clin Imaging 2018;49:12-16
- Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009;250:638-647
- Sarsiat L, Watkinson G, Turnbull A, Diana A, Oikonomidou O. Primary acinic cell carcinoma of the breast is associated with a poor outcome: a case report and literature review. Mol Clin Oncol 2022;16:43
- Fong Y, Evans J, Brook D, Kenkre J, Jarvis P, Gower-Thomas K. The Nottingham Prognostic Index: five- and ten-year data for all-cause survival within a screened population. Ann R Coll Surg Engl 2015;97:137-139